Nabriva Therapeutics plc·4

Dec 28, 7:04 PM ET

Naftzger J. Christopher 4

4 · Nabriva Therapeutics plc · Filed Dec 28, 2021

Insider Transaction Report

Form 4
Period: 2021-12-27
Naftzger J. Christopher
General Counsel and Corp Sec
Transactions
  • Purchase

    Ordinary Shares

    2021-12-27$0.59/sh+7,000$4,1307,000 total

Documents

1 file
  • 4
    tm2136401-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT